Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer

Both induction chemotherapy and concurrent low-dose cisplatin have been shown to improve results of thoracic irradiation in the treatment of locally advanced non-small-cell lung cancer (NSCLC). This phase II study was designed to investigate activity and feasibility of a novel chemoradiation regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardizzoni, A, Grossi, F, Scolaro, T, Giudici, S, Foppiano, F, Boni, L, Tixi, L, Cosso, M, Mereu, C, Ratto, G Battista, Vitale, V, Rosso, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362873/
https://www.ncbi.nlm.nih.gov/pubmed/10496358
http://dx.doi.org/10.1038/sj.bjc.6990693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362873/
https://www.ncbi.nlm.nih.gov/pubmed/10496358
http://dx.doi.org/10.1038/sj.bjc.6990693

Ejemplares similares